Torrent is already marketing the biosimilar of Rituximab under the brand name Toritz in oncology segment while a super speciality division for nephrology launched in 2014 is marketing the biosimilar of Darbepoetin alpha (Darbatitor). Torrent's Adfrar will be available as pre-filled syringe of 40mg, and the company plans to promote its drug to rheumatologists, gastroenterologists and dermatologists pan India.įor this, three separate super speciality task force have been introduced, and around 100 trained professionals are employed in these greenfield divisions.
